Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Achim Fischer is active.

Publication


Featured researches published by Achim Fischer.


Journal of Neurochemistry | 2004

Identification of regulated genes during permanent focal cerebral ischaemia: characterization of the protein kinase 9b5/MARKL1/MARK4

Armin Schneider; Rico Laage; Achim Fischer; Moritz J. Rossner; Sigrid Scheek; Sylvia Grünewald; Rohini Kuner; Daniela Weber; Carola Krüger; Bettina Klaussner; Bernhard Götz; Holger Hiemisch; Dieter Newrzella; Ana Martin-Villalba; Alfred Bach; Markus Schwaninger

Cerebral ischaemia induces transcriptional changes in a number of pathophysiologically important genes. Here we have systematically studied gene expression changes after 90 min and 24 h of permanent focal ischaemia in the mouse by an advanced fragment display technique (restriction‐mediated differential display). We identified 56 transcriptionally altered genes, many of which provide novel hints to ischaemic pathophysiology. Particularly interesting were two pro‐apoptotic genes (Grim19 and Tdag51), whose role in cerebral ischaemia and neuronal cell death has not been recognized so far. Among the unknown sequences, we identified a gene that was rapidly and transiently up‐regulated. The encoded protein displayed high homology to the MARK family of serine–threonine protein kinases and has recently been described as MARKL1/MARK4. Here we demonstrate that this protein is a functional protein kinase with the ability to specifically phosphorylate a cognate peptide substrate for the AMP‐kinase family. Upon overexpression in heterologous cells, the functional wild‐type protein, but not its kinase‐dead mutant, led to decreased cell viability. We conclude that the up‐regulation of this kinase during focal ischaemia may represent an interesting new target for pharmacological intervention.


Journal of Cerebral Blood Flow and Metabolism | 2004

Restriction-mediated differential display (RMDD) identifies pip92 as a pro-apoptotic gene product induced during focal cerebral ischemia

Armin Schneider; Achim Fischer; Daniela Weber; Sigrid Scheek; Carola Krüger; Moritz J. Rossner; Bettina Klaussner; Nadine Faucheron; Birgitta Kammandel; Bernhard Goetz; Oliver Herrmann; Alfred Bach; Markus Schwaninger

Studies of gene expression changes after cerebral ischemia can provide novel insight into ischemic pathophysiology. Here we describe application of restriction-mediated differential display to screening for differentially expressed genes after focal cerebral ischemia. This method combines the nonredundant generation of biotin-labeled fragment sets with the excellent resolution of direct blotting electrophoresis, reliable fragment recovery, and a novel clone selection strategy. Using the filament model in mouse with 90 minutes MCA occlusion followed by 2, 6, and 20 hours reperfusion, we have compared gene expression in sham-operated animals to both the ipsi- and contralateral forebrain hemisphere of ischemic mice. Our screening method has resulted in the identification of 70 genes differentially regulated after transient middle cerebral artery occlusion (MCAO), several of which represent unknown clones. We have identified many of the previously published regulated genes, lending high credibility to our method. Surprisingly, we detected a high degree of correspondent regulation of genes in the nonischemic hemisphere. A high percentage of genes coding for proteins in the respiratory chain was found to be up-regulated after ischemia, potentially representing a new mechanism involved in counteracting energy failure or radical generation in cerebral ischemia. One particularly interesting gene, whose upregulation by ischemia has not been described before, is pip92; this gene shows a rapid and long-lasting induction after cerebral ischemia. Here we demonstrate that pip92 induces cell death in primary neurons and displays several hallmarks of pro-apoptotic activity upon overexpression, supporting the notion that we have identified a novel pathophysiological player in cerebral ischemia. In summary, restriction-mediated differential display has proven its suitability for screening complex samples such as brain to reliably identify regulated genes, which can uncover novel pathophysiological mechanisms.


Experimental Neurology | 2006

Long-term gene expression changes in the cortex following cortical ischemia revealed by transcriptional profiling.

Carola Krüger; Durmus Cira; Clemens Sommer; Achim Fischer; Wolf-Rüdiger Schäbitz; Armin Schneider

Cerebral ischemia evokes changes in gene expression time-dependently after the ischemic event. Most studies on transcriptional changes following ischemia have centered on relatively early postischemic time points, and detected multiple genes relevant to neuronal cell death. However, functional outcome after ischemia depends critically on adaptations of the postischemic brain. Plasticity may derive from network-inherent changes, or from the formation of new nerve cells in the CNS. We have screened for gene expression changes up to 3 weeks following a limited photothrombotic cortical insult in the rat sensorimotor cortex by using the sensitive restriction-mediated differential display (RMDD) technique. A high number of genes were detected as induced at early or intermediate time points in the ipsi- and contralateral cortex (6 and 48 h). Unexpectedly, at the late time point examined (3 weeks), we still detected 40 genes that were changed in their expression. We further characterized the expression of two genes linked to neurogenesis (nestin and stathmin), and two genes likely involved in reconfiguring neuronal networks (semaphorin VIa and synaptotagmin IV). Conclusively, our data highlight the degree of long-term transcriptional changes in the cortex after ischemia, and provide insight into functional pathways of relevance for compensatory recovery mechanisms in neural networks.


Pharmacogenomics | 2002

Yellow pages to the transcriptome

Julia Scheel; Marie-Charlotte von Brevern; Andreas Hörlein; Achim Fischer; Armin Schneider; Alfred Bach


Archive | 2003

Constant length signatures for parallel sequencing of polynucleotides

Achim Fischer; Holger Hiemisch; Steven R. Williams; Sydney Brenner; Roger Walker; Eric Vermaas; Rongdian Fu


Molecular Brain Research | 2004

Identification of regulated genes during transient cortical ischemia in mice by restriction-mediated differential display (RMDD).

Armin Schneider; Achim Fischer; Carola Krüger; Jaroslaw Aronowski


Archive | 2001

Neuronal serine-threonine protein kinase

Armin Schneider; Bettina Klaussner; Achim Fischer; Dieter Newrzella; Bernhard Götz; Moritz Rossner; Gisela Eisenhardt; Rohini Kuner; Annette Trutzel; Birgitta Kammandel; Stephanie Jomana Naim; Markus Schwaninger


Archive | 2001

Nucleic acid molecule encoding a neuronal serine-threonine protein kinase

Armin Schneider; Bettina Klaussner; Achim Fischer; Dieter Newrzella; Bernhard Götz; Moritz J. Rossner; Gisela Eisenhardt; Rohini Kuner; Annette Trutzel; Birgitta Kammandel; Stephanie Jomana Naim; Markus Schwaninger


Pharmacogenomics | 2003

Macroresults for Microarrays – an array of possibilities

Achim Fischer


Archive | 2003

Signaturen konstanter länge für das parallele sequenzieren von polynukleotiden Signatures constant length for the parallel sequencing of polynucleotides

Achim Fischer; Holger Hiemisch; Steven R. Williams; Sydney Brenner; Roger Walker; Eric Vermaas; Rongdian Fu

Collaboration


Dive into the Achim Fischer's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Rongdian Fu

Molecular Sciences Institute

View shared research outputs
Top Co-Authors

Avatar

Steven R. Williams

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge